Report ID: SQMIG35A3093
Skyquest Technology's expert advisors have carried out comprehensive research and identified these companies as industry leaders in the Surgical Robots Market. This Analysis is based on comprehensive primary and secondary research on the corporate strategies, financial and operational performance, product portfolio, market share and brand analysis of all the leading Surgical Robots industry players.
The global surgical robots market is growing as more patients are requesting non-invasive surgical options, which provide greater accuracy and less possibility for errors due to bleeding, longer hospital stays, and recovery times than traditional procedures. The increase in chronic illness and disease, especially cardiovascular disease, cancer, and urology, has increased the use and demand for robotic-assisted surgical techniques in hospitals around the globe.
According to SkyQuest Technology “Surgical Robots Market By Offering (Instruments & Acessories, Services), By Application (General Surgery, Orthopedic Surgery), By End User (Hospitals & Clinics, Ambulatory Surgery Centers), By Control Mode, By Region- Industry Forecast 2025-2032,” Global Surgical Robots Market is projected to grow at a CAGR of over 13.4% by 2032, on account of urgent need for automating quantified data. Technological advancements in surgical robot technology, such as advancements in 3D imaging, the integration of artificial intelligence (AI) with surgical platforms, haptic feedback capabilities in robotic arms, and greater flexibility in surgical instruments, are providing surgeons with improved capabilities to perform surgeries more accurately and expeditiously. Furthermore, the lack of available qualified surgeons, increasing volume of surgeries, and a desire to have the best possible outcome from surgery are driving health care organizations to utilize robotic surgeries and invest in technologies that increase speed and accuracy.
|
Company |
Est. Year |
Headquarters |
Revenue |
Key Services |
|
Intuitive Surgical |
1995 |
Sunnyvale, CA, USA |
7.12 Billion USD (2023) |
Minimally Invasive General Surgery. Flagship da Vinci Surgical System (Xi, X, SP) for general, urologic, gynecologic, and cardiothoracic procedures. Also, the Ion endoluminal system for lung biopsy. |
|
Stryker Corporation |
1941 |
Kalamazoo, MI, USA |
20.50 Billion USD (2023) |
Orthopedic Robotic Surgery. Mako SmartRobotics platform for robotic-assisted partial knee, total knee, and total hip replacement surgeries. |
|
Medtronic plc |
1949 |
Dublin, Ireland |
32.36 Billion USD (FY 2024) |
General and Spinal Surgery. Hugo robotic-assisted surgery system for soft tissue procedures; Mazor X Stealth Edition for robotic-assisted spinal surgery. |
|
Johnson & Johnson |
1886 |
New Brunswick, NJ, USA |
30.40 Billion USD (2023) |
General and Endoluminal Surgery. Ottava (soft tissue surgery, currently in development/initial clinical phase); Monarch Platform (through Auris Health) for bronchoscopy and urology. |
|
Zimmer Biomet |
1927 |
Warsaw, IN, USA |
7.40 Billion USD (2023) |
Orthopedic Robotic Surgery. ROSA® (Robotic Surgical Assistant) System for total knee, partial knee, and hip replacement procedures, and spinal applications. |
|
Globus Medical |
2003 |
Audubon, PA, USA |
1.57 Billion USD (2023) |
Spinal and Orthopedic Robotics. ExcelsiusGPS™ robotic navigation platform for precise spinal surgery trajectory and implant placement. |
|
Smith & Nephew |
1856 |
London, UK |
5.55 Billion USD (2023) |
Orthopedic Robotic Surgery. CORI Surgical System for robotic-assisted knee and total hip replacement. |
|
CMR Surgical |
2014 |
Cambridge, UK |
Not disclosed |
Minimally Invasive General Surgery. Versius Surgical Robotic System, a versatile, modular system for general surgery, gynecology, and urology. |
|
Renishaw plc |
1973 |
Wotton-under-Edge, UK |
Not disclosed |
Neurosurgery. Neuromate Stereotactic Robot for neurosurgical procedures, including deep brain stimulation (DBS) and electrode placement. |
|
Asensus Surgical |
1992 |
Research Triangle Park, NC, USA |
USD 8.6 Million (2023) |
Digital Laparoscopy/Soft Tissue. Senhance Surgical System featuring haptic feedback and eye-tracking camera control, offering a digital laparoscopy solution. |
Intuitive Surgical Company is the undisputed worldwide leader in surgical robotics. Intuitive Surgical has almost single-handedly created and defined the surgical robotics marketplace. Intuitive Surgical's flagship platform, the da Vinci Surgical System includes the da Vinci Xi, da Vinci X, and da Vinci SP (single port) robotic systems and software is currently the most widely used surgical robotic system for soft-tissue procedures globally today including (but are not limited to) General Surgery, Urology, Gynecology and Cardiothoracic Surgery.
Stryker Corporation is a large diversified medical technology player and holds a strong position within the orthopedic robotic marketplace and their main product is the new Mako SmartRobotics system that provides surgeons with increased precision and personalization during knee and hip replacement procedures.
Medtronic PLC is considered one of the largest medical device manufacturers in the world and as such has invested heavily into the surgical robotic market to compete with the leader in soft-tissue robotic surgery. Medtronic's primary platform within the soft-tissue robotic surgery segment is the Hugo Robotic-Assisted Surgery (RAS) system, a modular surgical robotic system that was designed to provide greater flexibility and to reduce the cost and accessibility barriers for hospitals.
Johnson and Johnson is a significant new competitor entering the surgical robotic space with an established medical technology division and efforts focused on building a wide-ranging product portfolio across the surgical specialties. J&J's recent acquisition of Auris Health will enhance JJ's portfolio by adding the Monarch Platform for use in endoluminal surgical procedures, primarily bronchoscopy and Urology.
Zimmer Biomet's primary business focus is Orthopaedic Services, including Joint Replacement. A key part of their business is the ROSA® (Robotically Assisted Surgery) system designed to assist surgeons with total knee replacement, partial knee replacement, hip replacement, and spinal surgery.
Smith & Nephew develop advanced medical technologies. They focus primarily on orthopaedics (surgical procedures involving bones) and sports medicine. They have also developed the CORI Surgical System (robotic-assisted surgical system). This is a modern compact handheld surgical robot that can be used for a total or partial knee replacement.
CMR Surgical has rapidly established itself as a global company, originating from the United Kingdom, with their Versius Surgical Robotics System. The Versius Surgical Robotic System is unique due to its modular construction, enabling the use of only as many robotic arms as necessary by each hospital for different procedures.
Renishaw is an international engineering and scientific technologies group. Their expertise has led to a focus on Neurosurgery with respect to Surgical Robotics. Their main product is Neuromate® Stereotactic Robots which provide dependable and repeatable placement of surgical instruments into locations in the human brain.
Globulus Medical is a vertically integrated manufacturer of spinal surgical devices and orthopedic implants who have turned their focus towards utilizing robotics through integration of navigation systems for assistance during these procedures; their primary robotic solution, Excelsius GPS™, is a robotically guided navigation tool that offers the ability to map the precise direction and dimension of screws, for example, before insertion with 3D imaging using either a CT or intraoperative fluoroscope.
Asensus Surgical was previously known as TransEnterix. This company is focused on developing solutions that improve the performance of minimally invasive general and soft tissue surgery through the Senhance Surgical System, a Digital Laparoscopy System that demonstrates a desire to combine aspects of both methods of surgery (i.e., laparoscopic and robotic), while reducing the costs of each.
The global surgical robots market appears ready for significant growth due to the increasing trend of hospitals and surgical centers converting to using highly precise and minimally invasive techniques in order to increase favorable results for patients while also improving operational efficiencies. These trends are being accelerated through advancements in robotics, artificial intelligence (AI), and imaging technologies that continue to enhance the capabilities and dependability of surgical systems. This has resulted in an increase in the use of surgical robots in all surgical specialties, including Orthopaedics, Urology, Gynaecology, and General Surgery.
REQUEST FOR SAMPLE
Global Surgical Robots Market size was valued at USD 8.73 Billion in 2024 and is poised to grow from USD 9.9 Billion in 2025 to USD 27.08 Billion by 2033, growing at a CAGR of 13.4% in the forecast period (2026–2033).
The surgical robots industry is highly competitive and innovation-driven, with key players actively pursuing strategic initiatives such as mergers, acquisitions, product launches, and AI integration to strengthen their market position. Intuitive Surgical continues to lead the market with its da Vinci platform, and in 2024, the company introduced the da Vinci 5 system with enhanced precision and haptic feedback, capturing significant hospital adoption across North America. 'Intuitive Surgical', 'Medtronic', 'Stryker Corporation', 'Zimmer Biomet', 'Smith+Nephew', 'CMR Surgical', 'Asensus Surgical', 'Johnson & Johnson (Ethicon)', 'Renishaw plc', 'THINK Surgical', 'Siemens Healthineers', 'Karl Storz'
One of the primary drivers propelling the surgical robots market is the growing preference for minimally invasive surgeries (MIS). Patients and healthcare providers alike favor MIS due to advantages such as smaller incisions, reduced pain, quicker recovery times, and shorter hospital stays. Surgical robots enhance these benefits by providing unparalleled precision, better control, and improved visualization for surgeons. This demand is particularly strong in areas like gynecology, urology, and general surgery, where robotic systems enable complex procedures with lower complication risks. The push for patient-centered care and reduced healthcare costs further amplifies the adoption of robotic-assisted MIS worldwide.
Integration of Artificial Intelligence and Automation: AI integration is one of the most transformative market trends shaping the surgical robots market. From preoperative planning to intraoperative guidance and post-surgical analytics, AI is being used to improve accuracy, automate decision-making, and enhance learning for both systems and surgeons. In 2024, AI-trained robots demonstrated capabilities such as autonomous suturing and gallbladder removal in animal models, marking a major step toward intelligent surgical automation. AI is also enabling platforms like Asensus Surgical’s AugmentOR to evaluate surgical performance and reduce variability across surgeons.
As per regional outlook, North America is the largest and most mature market, characterized by widespread adoption, significant R&D investment, and a high concentration of global market leaders. The region benefits from strong healthcare infrastructure, high surgical volumes, and favorable regulatory environments that facilitate the introduction of next-generation robotic systems. Continuous innovation and early access to AI-enabled surgical platforms have positioned North America at the forefront of robotic-assisted surgery.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
Report ID: SQMIG35A3093
sales@skyquestt.com
USA +1 351-333-4748